ESC Premium Access

Antithrombotic therapy in stable cardiovascular disease - Represented in NEJM by the COMPASS trial and the PEGASUS-TIMI 54 trial

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Congress Presentation

About the speaker

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)
37 presentations
0 follower

3 more presentations in this session

Antithrombotic therapy in patients with atrial fibrillation undergoing PCI – Represented in NEJM by the PIONEER-AF PCI trial and the RE-DUAL PCI trial

Speaker: Professor C. Cannon (Boston, US)


Fractional Flow Reserve-Guided PCI – represented in NEJM by the FAME, FAME-2, Compare-Acute, IFR-SWEDEHEART, and DEFINE-FLAIR trials

Speaker: Professor E. Barbato (Rome, IT)


PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

Speaker: Professor L. Soendergaard (Copenhagen, DK)


Access the full session

Highlights from the New England Journal of Medicine: Editors’ Choice

Speakers: Doctor J. Eikelboom, Professor C. Cannon, Professor E. Barbato, Professor L. Soendergaard

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb